Search other topics…

People often wonder about the prevalence of Amyotrophic Lateral Sclerosis, asking 'how common is ALS?'

This article aims to shed some light on the numbers, looking at who gets it, where it happens, and how it compares to other conditions.

How Do Incidence and Prevalence Rates Help Us Understand ALS Statistics?

What Is the Difference Between ALS Incidence and ALS Prevalence?

When we talk about how common Amyotrophic Lateral Sclerosis (ALS) is, it's important to understand two key terms: incidence and prevalence. They sound similar, but they tell us different things about the disease.

Incidence refers to the number of new cases of ALS diagnosed within a specific time period, usually a year. Think of it as a snapshot of how many people are newly diagnosed each year.

Prevalence, on the other hand, is the total number of people living with ALS at a particular point in time. This includes both newly diagnosed individuals and those who have been living with the disease for some time.

Globally, the incidence of ALS is estimated to be between 1 and 2 new cases per 100,000 people each year. Prevalence figures tend to be higher, often ranging from 4 to 5 people per 100,000.

These numbers can vary based on factors like age, geographical location, and the accuracy of data collection methods.

Why Is Accurate Statistical Data on ALS Difficult to Collect?

Gathering precise statistics on ALS isn't always straightforward. Several factors can make data collection challenging:

  • Diagnostic Complexity: ALS can be difficult to diagnose definitively, especially in its early stages. Symptoms can overlap with other neurological conditions, leading to delays or misdiagnoses. This means some cases might not be captured in incidence data.

  • Varied Reporting Systems: Different countries and even regions within countries have varying systems for tracking diseases. Some may have robust national registries, while others rely on less centralized or comprehensive methods. This inconsistency can make it hard to compare data globally.

  • Patient Mobility and Data Silos: People may move between different healthcare systems or geographical areas, making it difficult to track their diagnosis and status consistently. Data might also be held in separate systems that don't easily communicate with each other.

  • Underdiagnosis in Certain Regions: In areas with limited healthcare resources or access to specialized neurological care, ALS may be underdiagnosed or misattributed to other causes. This can lead to an underestimation of the true prevalence and incidence rates.

These challenges mean that while we have a general idea of ALS statistics, the exact numbers are always estimates, and ongoing efforts are made to improve data accuracy and consistency.

What Does the Demographic Breakdown of ALS Patients Show?

When we talk about ALS, understanding who it affects is just as important as understanding the disease itself. While ALS can strike anyone, certain patterns emerge when we look at the statistics.

These demographic details help researchers and healthcare providers better understand risk factors and potentially tailor support.

At What Age Do Most ALS Diagnoses Occur?

Age is perhaps the most significant factor associated with ALS. The disease typically appears in middle to late adulthood. Most diagnoses occur in people between the ages of 40 and 80. It's quite rare for ALS to be diagnosed in individuals younger than 20, and cases in this age group are often linked to specific genetic forms of the disease.

As people get older, the likelihood of developing ALS increases. This age-related trend is observed across most populations studied.

Are Men More Likely to Develop ALS Than Women?

Historically, studies have shown a slightly higher incidence of ALS in men compared to women. This ratio is often cited as around 1.2 to 1.5, meaning men are diagnosed more frequently than women.

However, this difference appears to narrow in older age groups. The reasons for this observed sex difference are not fully understood and are an area of ongoing research.

It's possible that hormonal factors, environmental exposures, or genetic predispositions play a role, but more investigation is needed.

How Does ALS Prevalence Vary Across Different Races and Ethnicities?

ALS affects people of all races and ethnicities. However, most of the large-scale epidemiological studies have been conducted in populations of European descent. This means that data on ALS prevalence in other racial and ethnic groups can be less detailed.

Some research suggests potential differences in incidence or survival rates among different groups, but these findings are not always consistent and require further study. It's important to ensure that research and clinical trials include diverse populations to get a complete picture of the disease.

In Which Geographical Regions Is ALS Most Common Globally?

What Do Global Hotspots and Cold Spots Reveal About ALS Rates?

When we look at the global picture of Amyotrophic Lateral Sclerosis the numbers can vary quite a bit from one region to another. Some areas seem to have higher rates of diagnosis than others, though pinpointing exact reasons is complex.

Researchers are always looking at this data to see if there are patterns related to genetics, environment, or even how well the disease is tracked in different countries. Understanding these geographical differences helps us get closer to figuring out what causes ALS.

How Do ALS Incidence and Prevalence Rates Compare Between North America and Europe?

In North America and Europe, ALS is generally considered a relatively rare disease, but the incidence and prevalence rates are among the more consistently studied.

For instance, studies often show an annual incidence rate of about 2 new cases per 100,000 people in these regions. Prevalence, which is the total number of people living with ALS at a given time, might be around 5 cases per 100,000.

These figures can fluctuate based on the specific population studied and the methods used for data collection. Factors like an aging population and improved diagnostic capabilities might contribute to the observed numbers.

Why Is There a Scarcity of Accurate ALS Statistical Data in Asia and Africa?

When we turn our attention to Asia and Africa, the picture becomes less clear. There's a significant scarcity of comprehensive data on ALS in many parts of these continents.

This doesn't necessarily mean ALS is less common there; it more likely reflects challenges in healthcare infrastructure, diagnostic resources, and systematic data collection. In some areas, ALS might be underdiagnosed or misdiagnosed due to a lack of specialized neurological care.

Efforts are underway to improve data gathering in these regions, which will be vital for a truly global understanding of the disease. Without this information, we can't accurately compare rates or identify potential unique factors at play.

Which Specific Populations Have a Higher Documented Risk of ALS?

What Is the Connection Between Military Service and an Increased Risk of ALS?

Research has pointed to a connection between military service and an increased risk of developing Amyotrophic Lateral Sclerosis. While the exact reasons are still being explored, several factors associated with military life are under investigation.

These can include exposure to certain environmental toxins, combat-related injuries, and the physical and psychological stresses of service. Studies have observed higher rates of ALS among veterans compared to the general population, particularly those who served in specific conflicts or had certain occupational roles within the military.

The scientific community continues to gather data to better understand this association and identify potential contributing elements.

Does Athletic Participation and Repetitive Physical Trauma Increase ALS Risk?

Another area of interest is the potential link between participation in certain sports, especially those involving repetitive head impacts or physical trauma, and the risk of ALS.

While ALS is not solely a disease of athletes, some studies have suggested a higher incidence in individuals with a history of professional or high-level athletic careers, particularly in contact sports. The repetitive nature of impacts, concussions, or other physical stresses experienced by athletes is being examined as a possible factor.

However, it is important to note that this is a complex area of research, and a definitive causal link is still under investigation. Many factors contribute to ALS, and not all athletes will develop the condition.

How Can We Put Global ALS Prevalence Rates Into Context?

Is the Global Number of New ALS Diagnoses Increasing Over Time?

It's a question many people ask: are more people being diagnosed with ALS now than before?

Looking at the numbers, it appears that the incidence of ALS, meaning the number of new cases diagnosed each year, has seen a slight increase in some regions over recent decades.

This isn't necessarily because the disease itself is becoming more common in terms of its underlying biological causes. Instead, several factors likely contribute to this observed rise.

One significant factor is improved diagnostic capabilities and awareness. Medical professionals are generally better equipped to identify ALS, and diagnostic criteria have become more refined.

Furthermore, increased public awareness and patient advocacy mean that people may seek medical attention sooner, leading to earlier and more accurate diagnoses. Advances in medical imaging and neurological testing also play a role in distinguishing ALS from other conditions that might have similar early symptoms.

Therefore, the apparent increase in diagnosis rates may reflect better detection rather than a true surge in the disease's occurrence.

What Is the Statistical Breakdown Between Sporadic and Familial ALS Cases?

When we talk about ALS, it's important to distinguish between the two main forms: sporadic and familial.

Sporadic ALS is the most common type, accounting for about 90% to 95% of all cases. This means that in these instances, there's no known family history of the disease, and the cause is thought to be a combination of genetic mutations that occur by chance and environmental factors.

Familial ALS, on the other hand, makes up the remaining 5% to 10% of cases. In these situations, there is a clear genetic link, meaning the disease is passed down through families.

While the percentage is small, understanding familial ALS is vital for genetic research and identifying specific gene mutations that might play a role in the disease's development. Research into these genetic forms can sometimes shed light on the mechanisms involved in sporadic ALS as well.

How Does the Rarity of ALS Compare to Other Neurological Diseases?

ALS is often described as a rare disease, and when we compare its prevalence to other neurological conditions, this holds true.

For instance, Alzheimer's disease affects millions of people worldwide, with prevalence rates significantly higher than ALS. Similarly, conditions like Parkinson's disease and multiple sclerosis, while also serious, tend to have higher incidence and prevalence figures than ALS.

The rarity of ALS means that research funding and patient support, while growing, face unique challenges compared to more widespread neurological disorders. However, this rarity also underscores the importance of every case and every research effort aimed at understanding and treating this complex condition.

What Are the Key Conclusions Regarding Global ALS Prevalence and Statistics?

While ALS is a global company with a wide reach, it's important to remember that ALS, or Amyotrophic Lateral Sclerosis, is a rare disease. Statistics show it affects a small number of people each year, though the exact numbers can vary by region and how data is collected.

It tends to appear more often in certain age groups and can affect men’s brain health slightly more than women. Understanding these numbers helps us grasp the scale of the challenge and the importance of continued neuroscience-based research and support for those affected by this condition.

References

  1. Brotman, R. G., Moreno-Escobar, M. C., Joseph, J., Munakomi, S., & Pawar, G. (2025). Amyotrophic lateral sclerosis. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK556151/

  2. Ingre, C., Roos, P. M., Piehl, F., Kamel, F., & Fang, F. (2015). Risk factors for amyotrophic lateral sclerosis. Clinical epidemiology, 7, 181–193. https://doi.org/10.2147/CLEP.S37505

  3. Liu, X., He, J., Gao, F. B., Gitler, A. D., & Fan, D. (2018). The epidemiology and genetics of Amyotrophic lateral sclerosis in China. Brain research, 1693(Pt A), 121–126. https://doi.org/10.1016/j.brainres.2018.02.035

  4. McKay, K. A., Smith, K. A., Smertinaite, L., Fang, F., Ingre, C., & Taube, F. (2021). Military service and related risk factors for amyotrophic lateral sclerosis. Acta neurologica Scandinavica, 143(1), 39–50. https://doi.org/10.1111/ane.13345

  5. Blecher, R., Elliott, M. A., Yilmaz, E., Dettori, J. R., Oskouian, R. J., Patel, A., ... & Chapman, J. R. (2019). Contact sports as a risk factor for amyotrophic lateral sclerosis: a systematic review. Global spine journal, 9(1), 104-118. https://doi.org/10.1177/219256821881391

Frequently Asked Questions

Is ALS more common in men or women?

ALS affects men slightly more often than women. For every 100,000 people, about 2 men and 1.6 women are diagnosed each year.

What is the typical age when someone is diagnosed with ALS?

Most people are diagnosed with ALS between the ages of 40 and 80. However, younger people can also get the disease, though it's less common.

Does ALS affect people of all races and ethnic groups?

Yes, ALS can affect people from all racial and ethnic backgrounds. Current studies show it appears to be slightly more common in White individuals compared to other groups.

Are there places where ALS is more common?

While ALS occurs worldwide, certain small areas have shown higher rates, but scientists are still studying why this might be.

Is there a link between military service and ALS?

Studies have shown that veterans have a higher risk of developing ALS. The exact reasons are still being researched.

Can athletes get ALS?

Some research suggests that athletes, particularly those involved in sports with repeated head impacts or intense physical activity, might have a slightly higher chance of developing ALS. More study is needed.

Is ALS inherited?

In most cases, ALS is considered 'sporadic,' meaning it occurs randomly. However, about 5-10% of ALS cases are 'familial,' which means they are passed down through families due to a gene change.

How common is ALS compared to other brain diseases?

ALS is considered a rare disease. It affects far fewer people than more common neurological conditions like Alzheimer's disease or Parkinson's disease.

Emotiv is a neurotechnology leader helping advance neuroscience research through accessible EEG and brain data tools.

Medical Disclaimer: The information provided on this website is for educational and informational purposes only and is not intended as medical or health advice. This content may contain errors and should not be relied upon to make life-altering health, medical, or lifestyle choices. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or treatment.

Christian Burgos

Latest from us

The Dry EEG Electrode Trade-Off: Speed and Comfort vs. Signal Fidelity

The electroencephalogram (EEG) has been a cornerstone of neuroscience for decades, measuring the brain’s electrical activity through electrodes placed on the scalp. Traditional “wet” electrodes require conductive gel to bridge the gap between skin and sensor, reducing the resistance—impedance—that would otherwise block these tiny voltages. That gel application is messy, time‑consuming, and often uncomfortable for participants.

As EEG moves outside the laboratory—into homes, clinics, and ambulatory settings—the demand for a faster, simpler interface has grown. Dry electrodes, which make direct contact with the skin without gel, promise exactly that: rapid setup and greater comfort.

But this convenience carries a physical cost. The absence of gel introduces higher impedance and a noisier signal, creating a consistent trade‑off between practicality and data fidelity. A body of recent independent research now maps the precise dimensions of that trade‑off, clarifying where dry electrodes perform admirably and where they remain a second choice.

Read article

How Does Home EEG Work for Daily Brain Recording?

Home EEG are self-administered recordings performed outside any clinical or laboratory setting. It hands the electrode gel, the headset, and the recording software to an untrained user, often with nothing more than a smartphone app for guidance. The concept consists of having brain measurement capabilities that fits into daily life, potentially recording sleep architecture, cognitive focus, or seizure patterns without the logistical burden of a hospital visit.

Read article

Neurofeedback Devices as Whole Systems

Imagine playing a video game where your controller is invisible—you steer with nothing but your own brainwaves. That idea sits at the core of neurofeedback, a technique that gives you a real‑time window into your brain’s activity and then teaches you to shift it.

A device picks up signals generated by your brain, most often using an electroencephalogram (EEG) that detects electrical patterns on the scalp, or occasionally a functional near‑infrared spectroscopy (fNIRS) sensor that tracks blood flow. Those raw signals are processed and turned into a simple game, a sound, or a moving figure on a screen. Through trial and error, your brain learns to produce the patterns that make the feedback go in the direction you want.

A lot of guides focus on the individual parts—the EEG electrodes, the wires, the software—but a device only succeeds when those pieces form a coherent whole. This introduction examines neurofeedback as an integrated system where signal processing, feedback design, and everyday usability combine to determine whether something genuinely helps.

Read article

Master EEG Setup: Pre-Recording Best Practices

What separates a clear, interpretable neural signal from a trace corrupted by muscle artifact or line noise is not a sophisticated post-hoc algorithm, but a systematic, chronological pipeline of preparatory steps. EEG setup, in this context, is not simply the act of placing an electrode cap on a participant. It is a disciplined sequence of biological, environmental, and electrical calibration procedures that collectively establish a stable, low-noise interface between the brain and the amplifier.

This article walks through the pre-recording workflow, synthesizing available evidence to demonstrate that careful participant briefing, scalp preparation, environmental shielding, reference montage selection, and baseline artifact screening form a non-negotiable chain of dependencies.

Read article